SWM
AGN

SeaCrest Wealth Management’s Allergan plc AGN Stock Holding History

SeaCrest Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,178
Closed -$172K – 2117
2019
Q1 		$172K Sell
1,178
-949
-45% -$138K 0.03% 521
2018
Q4 		$284K Sell
2,127
-1,437
-40% -$236K 0.06% 346
2018
Q3 		$679K Sell
3,564
-26
-0.7% -$4.78K 0.11% 187
2018
Q2 		$599K Buy
3,590
+1,467
+69% +$236K 0.11% 209
2018
Q1 		$357K Buy
2,123
+363
+21% +$60.9K 0.07% 329
2017
Q4 		$288K Buy
+1,760
New +$316K 0.05% 382

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SeaCrest Wealth Management's AGN Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,178 shares — an estimated $172K sold.

SeaCrest Wealth Management first reported a position in AGN in Q4 2017 and held it in 6 quarters. The position peaked at $679K in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • SeaCrest Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 1,178 Allergan plc shares in Q2 2019, an estimated $172K.
  • SeaCrest Wealth Management first reported a position in Allergan plc in Q4 2017 and held it in 6 quarters.
  • SeaCrest Wealth Management's Allergan plc position peaked at $679K in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.